Combined Sodium-Glucose-Transporters Inhibitors and Glucagon-Like-Peptide Receptor Agonist Compared With Monotherapy Improves Long-Term Survival: A Real-World Registry

1. García-Vega, D.
2. Cinza-Sanjurjo, S.
3. Eiras, S.
4. González-Juanatey, J.R.